CA3135225A1 - Devices and methods for treating edema - Google Patents

Devices and methods for treating edema Download PDF

Info

Publication number: CA3135225A1
Authority: CA; Canada
Prior art keywords: impeller; catheter; expandable member; proximal; housing
Prior art date: 2019-02-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

CA3135225A

Other languages

English (en)

French (fr)

Inventor

Yaacov Nitzan

Ronan Keating

Shahaf MARMUR

Or INBAR

Eamon Brady

Gerry Mccaffrey

Reed WILLISTON

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

White Swell Medical Ltd

Original Assignee

White Swell Medical Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2019-02-26

Filing date

2020-02-26

Publication date

2020-09-03

2020-02-26 Application filed by White Swell Medical Ltd filed Critical White Swell Medical Ltd

2020-09-03 Publication of CA3135225A1 publication Critical patent/CA3135225A1/en

Status Pending legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 100
206010030113 Oedema Diseases 0.000 title claims abstract description 62
239000012530 fluid Substances 0.000 claims abstract description 104
230000001926 lymphatic effect Effects 0.000 claims abstract description 47
230000007423 decrease Effects 0.000 claims abstract description 24
210000004369 blood Anatomy 0.000 claims description 85
239000008280 blood Substances 0.000 claims description 85
210000003129 brachiocephalic vein Anatomy 0.000 claims description 46
239000012528 membrane Substances 0.000 claims description 15
229910052751 metal Inorganic materials 0.000 claims description 14
239000002184 metal Substances 0.000 claims description 14
230000007704 transition Effects 0.000 claims description 14
238000003780 insertion Methods 0.000 claims description 10
230000037431 insertion Effects 0.000 claims description 10
239000000853 adhesive Substances 0.000 claims description 7
230000001070 adhesive effect Effects 0.000 claims description 7
229920000642 polymer Polymers 0.000 claims description 7
238000005259 measurement Methods 0.000 claims 1
230000017531 blood circulation Effects 0.000 abstract description 22
238000011282 treatment Methods 0.000 abstract description 22
210000004324 lymphatic system Anatomy 0.000 abstract description 14
238000010926 purge Methods 0.000 description 59
239000003146 anticoagulant agent Substances 0.000 description 42
229940127219 anticoagulant drug Drugs 0.000 description 42
239000000463 material Substances 0.000 description 36
210000004731 jugular vein Anatomy 0.000 description 32
210000004204 blood vessel Anatomy 0.000 description 25
230000007246 mechanism Effects 0.000 description 25
239000003814 drug Substances 0.000 description 20
210000002751 lymph Anatomy 0.000 description 17
229920001343 polytetrafluoroethylene Polymers 0.000 description 16
239000004810 polytetrafluoroethylene Substances 0.000 description 16
206010019280 Heart failures Diseases 0.000 description 15
230000036961 partial effect Effects 0.000 description 15
210000001124 body fluid Anatomy 0.000 description 14
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 12
210000003462 vein Anatomy 0.000 description 12
206010007559 Cardiac failure congestive Diseases 0.000 description 11
238000004891 communication Methods 0.000 description 11
-1 polytetrafluoroethylene Polymers 0.000 description 11
206010053567 Coagulopathies Diseases 0.000 description 9
208000007536 Thrombosis Diseases 0.000 description 9
230000035602 clotting Effects 0.000 description 9
229960002897 heparin Drugs 0.000 description 9
229920000669 heparin Polymers 0.000 description 9
238000011144 upstream manufacturing Methods 0.000 description 9
210000005166 vasculature Anatomy 0.000 description 9
206010018910 Haemolysis Diseases 0.000 description 8
230000000694 effects Effects 0.000 description 8
230000008588 hemolysis Effects 0.000 description 8
230000008878 coupling Effects 0.000 description 7
238000010168 coupling process Methods 0.000 description 7
238000005859 coupling reaction Methods 0.000 description 7
239000000306 component Substances 0.000 description 6
238000010586 diagram Methods 0.000 description 6
238000001125 extrusion Methods 0.000 description 6
239000010839 body fluid Substances 0.000 description 5
230000008859 change Effects 0.000 description 5
230000002706 hydrostatic effect Effects 0.000 description 5
229920002635 polyurethane Polymers 0.000 description 5
239000004814 polyurethane Substances 0.000 description 5
229920002614 Polyether block amide Polymers 0.000 description 4
230000002411 adverse Effects 0.000 description 4
230000008901 benefit Effects 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
238000011010 flushing procedure Methods 0.000 description 4
230000002209 hydrophobic effect Effects 0.000 description 4
230000002452 interceptive effect Effects 0.000 description 4
229910001000 nickel titanium Inorganic materials 0.000 description 4
QNZCBYKSOIHPEH-UHFFFAOYSA-N Apixaban Chemical compound C1=CC(OC)=CC=C1N1C(C(=O)N(CC2)C=3C=CC(=CC=3)N3C(CCCC3)=O)=C2C(C(N)=O)=N1 QNZCBYKSOIHPEH-UHFFFAOYSA-N 0.000 description 3
HGVDHZBSSITLCT-JLJPHGGASA-N Edoxaban Chemical compound N([C@H]1CC[C@@H](C[C@H]1NC(=O)C=1SC=2CN(C)CCC=2N=1)C(=O)N(C)C)C(=O)C(=O)NC1=CC=C(Cl)C=N1 HGVDHZBSSITLCT-JLJPHGGASA-N 0.000 description 3
239000004677 Nylon Substances 0.000 description 3
239000004696 Poly ether ether ketone Substances 0.000 description 3
239000004952 Polyamide Substances 0.000 description 3
229960003886 apixaban Drugs 0.000 description 3
230000036772 blood pressure Effects 0.000 description 3
229960003850 dabigatran Drugs 0.000 description 3
YBSJFWOBGCMAKL-UHFFFAOYSA-N dabigatran Chemical compound N=1C2=CC(C(=O)N(CCC(O)=O)C=3N=CC=CC=3)=CC=C2N(C)C=1CNC1=CC=C(C(N)=N)C=C1 YBSJFWOBGCMAKL-UHFFFAOYSA-N 0.000 description 3
229960000622 edoxaban Drugs 0.000 description 3
229960000610 enoxaparin Drugs 0.000 description 3
KANJSNBRCNMZMV-ABRZTLGGSA-N fondaparinux Chemical compound O[C@@H]1[C@@H](NS(O)(=O)=O)[C@@H](OC)O[C@H](COS(O)(=O)=O)[C@H]1O[C@H]1[C@H](OS(O)(=O)=O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O[C@@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O4)NS(O)(=O)=O)[C@H](O3)C(O)=O)O)[C@@H](COS(O)(=O)=O)O2)NS(O)(=O)=O)[C@H](C(O)=O)O1 KANJSNBRCNMZMV-ABRZTLGGSA-N 0.000 description 3
229960001318 fondaparinux Drugs 0.000 description 3
230000006870 function Effects 0.000 description 3
229920001778 nylon Polymers 0.000 description 3
229920002647 polyamide Polymers 0.000 description 3
229920002530 polyetherether ketone Polymers 0.000 description 3
229920001296 polysiloxane Polymers 0.000 description 3
229960001148 rivaroxaban Drugs 0.000 description 3
KGFYHTZWPPHNLQ-AWEZNQCLSA-N rivaroxaban Chemical compound S1C(Cl)=CC=C1C(=O)NC[C@@H]1OC(=O)N(C=2C=CC(=CC=2)N2C(COCC2)=O)C1 KGFYHTZWPPHNLQ-AWEZNQCLSA-N 0.000 description 3
210000001321 subclavian vein Anatomy 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
210000002978 thoracic duct Anatomy 0.000 description 3
229960005080 warfarin Drugs 0.000 description 3
PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 3
206010007556 Cardiac failure acute Diseases 0.000 description 2
208000000059 Dyspnea Diseases 0.000 description 2
206010013975 Dyspnoeas Diseases 0.000 description 2
239000004812 Fluorinated ethylene propylene Substances 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
239000004697 Polyetherimide Substances 0.000 description 2
239000004642 Polyimide Substances 0.000 description 2
239000004743 Polypropylene Substances 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
229910000831 Steel Inorganic materials 0.000 description 2
239000004809 Teflon Substances 0.000 description 2
229920006362 Teflon® Polymers 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
210000000601 blood cell Anatomy 0.000 description 2
230000023555 blood coagulation Effects 0.000 description 2
230000015271 coagulation Effects 0.000 description 2
238000005345 coagulation Methods 0.000 description 2
239000008121 dextrose Substances 0.000 description 2
230000004941 influx Effects 0.000 description 2
230000003993 interaction Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
230000037361 pathway Effects 0.000 description 2
230000035515 penetration Effects 0.000 description 2
229920009441 perflouroethylene propylene Polymers 0.000 description 2
229920001601 polyetherimide Polymers 0.000 description 2
229920000139 polyethylene terephthalate Polymers 0.000 description 2
239000005020 polyethylene terephthalate Substances 0.000 description 2
229920001721 polyimide Polymers 0.000 description 2
229920001155 polypropylene Polymers 0.000 description 2
239000004800 polyvinyl chloride Substances 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000004044 response Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
230000003068 static effect Effects 0.000 description 2
239000010959 steel Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
COKMIXFXJJXBQG-NRFANRHFSA-N tirofiban Chemical compound C1=CC(C[C@H](NS(=O)(=O)CCCC)C(O)=O)=CC=C1OCCCCC1CCNCC1 COKMIXFXJJXBQG-NRFANRHFSA-N 0.000 description 2
229960003425 tirofiban Drugs 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
238000005406 washing Methods 0.000 description 2
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
229920000339 Marlex Polymers 0.000 description 1
ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
241001408665 Timandra griseata Species 0.000 description 1
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
230000004323 axial length Effects 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
239000012620 biological material Substances 0.000 description 1
239000012503 blood component Substances 0.000 description 1
210000001772 blood platelet Anatomy 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
230000004087 circulation Effects 0.000 description 1
239000000701 coagulant Substances 0.000 description 1
238000005094 computer simulation Methods 0.000 description 1
229920003020 cross-linked polyethylene Polymers 0.000 description 1
239000004703 cross-linked polyethylene Substances 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
230000036541 health Effects 0.000 description 1
210000002837 heart atrium Anatomy 0.000 description 1
210000001308 heart ventricle Anatomy 0.000 description 1
229920001903 high density polyethylene Polymers 0.000 description 1
239000004700 high-density polyethylene Substances 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
230000007794 irritation Effects 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
229920000092 linear low density polyethylene Polymers 0.000 description 1
239000004707 linear low-density polyethylene Substances 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
230000001151 other effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004033 plastic Substances 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
239000002861 polymer material Substances 0.000 description 1
229920000915 polyvinyl chloride Polymers 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000005086 pumping Methods 0.000 description 1
230000003134 recirculating effect Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000002787 reinforcement Effects 0.000 description 1
238000010008 shearing Methods 0.000 description 1
208000013220 shortness of breath Diseases 0.000 description 1
239000007779 soft material Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
230000003746 surface roughness Effects 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
239000010936 titanium Substances 0.000 description 1
229910052719 titanium Inorganic materials 0.000 description 1
238000011179 visual inspection Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/802—Constructional details other than related to driving of non-positive displacement blood pumps
- A61M60/81—Pump housings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
- A61M60/13—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel by means of a catheter allowing explantation, e.g. catheter pumps temporarily introduced via the vascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/205—Non-positive displacement blood pumps
- A61M60/216—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/40—Details relating to driving
- A61M60/403—Details relating to driving for non-positive displacement blood pumps
- A61M60/408—Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being mechanical, e.g. transmitted by a shaft or cable
- A61M60/411—Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being mechanical, e.g. transmitted by a shaft or cable generated by an electromotor
- A61M60/414—Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being mechanical, e.g. transmitted by a shaft or cable generated by an electromotor transmitted by a rotating cable, e.g. for blood pumps mounted on a catheter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/802—Constructional details other than related to driving of non-positive displacement blood pumps
- A61M60/833—Occluders for preventing backflow
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0405—Lymph

Landscapes

Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Mechanical Engineering (AREA)
Anesthesiology (AREA)
Cardiology (AREA)
Hematology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Vascular Medicine (AREA)
External Artificial Organs (AREA)

CA3135225A 2019-02-26 2020-02-26 Devices and methods for treating edema Pending CA3135225A1 (en)

Applications Claiming Priority (11)

Application Number	Priority Date	Filing Date	Title
US201962810668P	2019-02-26	2019-02-26
US201962810672P	2019-02-26	2019-02-26
US201962810660P	2019-02-26	2019-02-26
US201962810658P	2019-02-26	2019-02-26
US201962810653P	2019-02-26	2019-02-26
US62/810,668		2019-02-26
US62/810,653		2019-02-26
US62/810,672		2019-02-26
US62/810,660		2019-02-26
US62/810,658		2019-02-26
PCT/IB2020/000184 WO2020174285A2 (en)	2019-02-26	2020-02-26	Devices and methods for treating edema

Publications (1)

Publication Number	Publication Date
CA3135225A1 true CA3135225A1 (en)	2020-09-03

Family

ID=72239237

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA3135225A Pending CA3135225A1 (en)	2019-02-26	2020-02-26	Devices and methods for treating edema

Country Status (7)

Country	Link
EP (1)	EP3930600A4 (de)
JP (1)	JP2022523205A (de)
CN (1)	CN113727752A (de)
AU (1)	AU2020230048A1 (de)
CA (1)	CA3135225A1 (de)
IL (1)	IL285734A (de)
WO (1)	WO2020174285A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9901722B2 (en)	2014-06-01	2018-02-27	White Swell Medical Ltd	System and method for treatment of pulmonary edema
US10912873B2 (en)	2017-03-02	2021-02-09	White Swell Medical Ltd	Systems and methods for reducing pressure at an outflow of a duct
US11660426B2 (en)	2019-02-26	2023-05-30	White Swell Medical Ltd	Devices and methods for treating edema
US11931560B2 (en)	2019-02-26	2024-03-19	White Swell Medical Ltd	Devices and methods for treating edema
US11724095B2 (en)	2019-02-26	2023-08-15	White Swell Medical Ltd	Devices and methods for treating edema
US11717652B2 (en)	2019-02-26	2023-08-08	White Swell Medical Ltd	Devices and methods for treating edema
US11793996B2 (en)	2019-02-26	2023-10-24	White Swell Medical Ltd	Devices and methods for treating edema
WO2021250464A1 (en) *	2020-06-08	2021-12-16	White Swell Medical Ltd	Non-thrombogenic devices for treating edema

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6071273A (en) *	1988-02-29	2000-06-06	Scimed Life Systems, Inc.	Fixed wire dilatation balloon catheter
US5092844A (en) *	1990-04-10	1992-03-03	Mayo Foundation For Medical Education And Research	Intracatheter perfusion pump apparatus and method
US5643172A (en) *	1995-03-06	1997-07-01	Abiomed R & D, Inc.	Tubular circulatory assist device
DE19622335C2 (de) *	1996-06-04	1999-03-18	Voelker Wolfram Priv Doz Dr Me	Ballonkatheter
US6299596B1 (en) *	1998-03-20	2001-10-09	Schneider (Usa) Inc.	Method of bonding polymers and medical devices comprising materials bonded by said method
EP3534985A4 (de) *	2016-11-01	2020-06-10	White Swell Medical Ltd	Systeme und verfahren zur behandlung von flüssigkeitsüberlastung
DK3398626T3 (da) *	2017-05-04	2021-03-22	Abiomed Europe Gmbh	Intravaskulær blodpumpe med ballon
US11724095B2 (en) *	2019-02-26	2023-08-15	White Swell Medical Ltd	Devices and methods for treating edema

2020
- 2020-02-26 CN CN202080031482.0A patent/CN113727752A/zh active Pending
- 2020-02-26 EP EP20763700.0A patent/EP3930600A4/de active Pending
- 2020-02-26 AU AU2020230048A patent/AU2020230048A1/en active Pending
- 2020-02-26 CA CA3135225A patent/CA3135225A1/en active Pending
- 2020-02-26 WO PCT/IB2020/000184 patent/WO2020174285A2/en unknown
- 2020-02-26 JP JP2021549632A patent/JP2022523205A/ja active Pending
2021
- 2021-08-19 IL IL285734A patent/IL285734A/en unknown

Also Published As

Publication number	Publication date
EP3930600A2 (de)	2022-01-05
JP2022523205A (ja)	2022-04-21
WO2020174285A2 (en)	2020-09-03
AU2020230048A1 (en)	2021-09-23
WO2020174285A3 (en)	2021-04-01
EP3930600A4 (de)	2022-11-09
CN113727752A (zh)	2021-11-30
IL285734A (en)	2021-10-31

Legal Events

Date	Code	Title	Description
2023-11-23	EEER	Examination request	Effective date: 20231109
2024-02-16	EEER	Examination request	Effective date: 20231109

Publication	Publication Date	Title
US11931560B2 (en)	2024-03-19	Devices and methods for treating edema
US11660426B2 (en)	2023-05-30	Devices and methods for treating edema
US11724095B2 (en)	2023-08-15	Devices and methods for treating edema
US11793996B2 (en)	2023-10-24	Devices and methods for treating edema
US11717652B2 (en)	2023-08-08	Devices and methods for treating edema
CA3135225A1 (en)	2020-09-03	Devices and methods for treating edema
US20240058595A1 (en)	2024-02-22	Systems and methods for reducing pressure at an outflow of a duct
US6592567B1 (en)	2003-07-15	Kidney perfusion catheter
US7374560B2 (en)	2008-05-20	Emboli protection devices and related methods of use
WO2017159849A1 (ja)	2017-09-21	カテーテルポンプおよび処置方法
US20090069829A1 (en)	2009-03-12	Rotational Atherectomy Device with Distal Protection Capability and Method of Use
US20220104827A1 (en)	2022-04-07	Flow restricting intravascular devices for treating edema
JP2002535091A (ja)	2002-10-22	縮んだ位置でシールされるポートを備えたインペラ血液ポンプ。
US20220249830A1 (en)	2022-08-11	Percutaneous Blood Pump Systems and Related Methods
US20240173464A1 (en)	2024-05-30	Distal Flow Arterial Cannula with Expandable Positioning Balloon
US20230211142A1 (en)	2023-07-06	Filter for particles in catheter pump system